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ABSTRACT
Biologically active nickel(ll), copper(ll) and zinc(ll) chelates with thiazole-derived nitro- and
chlorosalicylaldehyde Schiff-bases having the same metal ion but different anions, e.g. nitrate,
sulfate, oxalate and acetate have been synthesized and characterized on the basis of their physical,
spectral and analytical data. In order to evaluate the possible participating role of anions on the
antibacterial properties, these ligands and their synthesized metal chelates with various anions have
been screened against bacterial species Escherichia co/i, Pseudomonas aeruginosa and
Staphylococcus aureus.
INTRODUCTION
Various thiazole compounds have been found to be associated with diverse antibacterial,
antifungal2, antitumour3, anticancer4 and anthelmintic5 activities. Many studies6-1 have described
the biological role of metals and chelation and have established the fact that those anticancer drugs
as viable ligands exhibit increased anticancer activity when administered as their metal chelates. The
connected metal centers in such biologically active molecules may involve different functions such
as oxygen transport, DNA inhibitor, enzymatic activity, electron transfer and lock geometry. All these
observations related to the essential role of metals linkage attracted our attention to commence a
systematic reseamh program -s to investigate the factors responsible for this relationship. During
the course of previous investigations thiazole-derived nitro- and chlorosalicylaldehyde Schiff-bases
and their various transition metal chelates were prepared6 as antibacterial agent and studied for this
relationship of metal chelation and the subsequent antibacterial properties. In continuation to the
same, during the present work we wish to extend the same studies hitherto the less investigated
possible participating biological role of anions on these prepared chelates, which stay as the
counterpart of the complexes. For this purpose thiazole-derived nitro- and chlorosalicylaldehyde
Schiff-bases (HL and HL2) (Fig. 1) and their metal chelates of the type [M(L)2X] [M=Ni(II), Cu(ll) and
Zn(ll), L=HL & HL2 (Fig.l) and X= NO3, SO42", C2042" and CH3CO2" having the same metal ion but
different anions were synthesized, characterized and screened for their antibacterial activity against
Escherichia co/i, Staphylococcus aureous and Pseudomonas aeruginosa
HLI: R NO2; HL2: R CI
Figure 1. Structure of the Schiff-bases
EXPERIMENTAL
Material and Methods
All chemicals and solvents used were of Analar grade. All metal were used as their nitrates, sulfates,
oxalates and acetates. IR spectra were recorded on a Philips Analytical PU 9800 FTIR
Spectrophotometer. UV-Visible spectra were obtained on a Hitachi U-2000 double-beam
spectrophotometer. Conductance of the metal complexes was determined in DMF on a YSI-32
model conductometer. Magnetic measurements were done on solid complexes using the Gouy
method. Melting points were recorded on a Gallenkamp apparatus and are uncorrected. The
antibacterial studies were carried out with the help of the Department of Pathology, Quaid-e-Azam
Medical College, Bahawalpur, Pakistan.
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Preparation of Schiff-bases
The ligands were prepared by adopting the same procedure as reported earlier16.
Preparation of Metal Complexes
An ethanol solution of appropriate metal(ll) salt (1 mmol, 20 mL) was added to a stirred hot ethanol
solution of the respective Schiff-base (2 mmol, 30 mL). The resulting mixture was refluxed for 3 h.
The solution was then cooled, filtered, reduced to nearly half its volume and then left for two days at
room temperature. During this period the product crystallized. It was filtered, washed with ethanol
and ether and dried to give the desired metal complexes 1 (62 %), 2 (60 %), 3 (58 %), 4 (61%), 5
(60 %), 6 (62 %), 7 (59 %), S (60 %), 9 (62 %), 10 (58 %), 11 (61%), 12 (62 %), 13 (61), 14 (60 %),
15 (59 %), 16 (58 %), 17 (62 %), 18 (60 %), 19 (62 %), 20 (59 %), 21 (60 %), 22 (61%), 23 (63
%) and 24 (60 %).
Antibacterial Studies
The synthesized metal chelates in comparison to the free ligand were screened for their antibacterial
activity against bacterial species Escherichia coli, Staphylococcus aureus and Pseudomonas
aeruginosa. The paper disc diffusion method was used for the determination of the antibacterial
activity.
Preparation of Discs.
The ligand/complex (30 Ig) in DMF (0.01mL) was applied on a paper disc, [prepared from blotting
paper (3 mm diameter)] with the help of a micropipette. The discs were left in an incubator for 48 h at
37 C and then applied on the bacteria grown agar plates.
Preparation of Agar Plates.
Minimal agar was used for the growth of specific bacterial species. For the preparation of agar plates
for Escherichia coil, MacConkey agar (50 g), obtained from Merck Chemical Company, was
suspended in freshly distilled water (1 L). It was allowed to soak for 15 minutes and then boiled on a
water bath until the agar was completely dissolved. The mixture was autoclaved for 15 minutes at
120 C and then poured into previously washed and sterilized Petri dishes and stored at 40 C for
inoculation.
Procedure of Inoculation.
Inoculation was done with the help of a platinum wire loop which was made red hot in a flame, cooled
and then use for the application of bacterial strains.
Application of Discs.
A sterilized forceps was used for the application of paper disc on the already inoculated agar plates.
When the discs were applied, they were incubated at 37 C for 24 h. The zone of inhibition was then
measured (in diameter) around the disc.
RESULT AND DISCUSSIONS
Physical Properties
Schiff-bases (Fig. 1) were prepared by reacting equimolar amounts of nitro- or chlorosalicylaldehyde
and 2-aminothiazole respectively in ethanol. The crystallized products after characterization were
reported earlier16 and now used further for the preparation of its Ni(ll), Cu(ll) and Zn(ll) complexes
having different anions as NO3, SO42-, C2042- and CH3CO2".
All the prepared complexes are crystalline solids and melt with decomposition above 245 C without
showing sharp melting points. The complexes are soluble in DMF, DMSO and benzene. Their
melting behavior, solubility and crystalline nature suggested that they are non-polymeric. Elemental
analysis data (Table 1) indicated 1:2 (metal:ligand) stoichiometry. Low conductance values (11-18
ohm-1 cm2 mo1-1) indicated that the complexes are non-electrolytes17,18.
Infrared Spectra
The detailed IR spectra of the ligands16 show a weak band at 2900 cm-1 instead of a broad medium
band at 3100 cm-1. This might be due to intramolecular hydrogen bonding between the phenolic (-
OH) hydrogen and the nitrogen of the azomethine group9. The absence of vOH in the complexes
suggested the deprotonation of the phenolic-OH group of the Schiff-base and its co-ordination
through oxygen atom. Moreover, the vC-O and vC=N modes which appeared at 1280 and 1630
cm-
respectively in the Schiff-bases were shifted in the complexes. This shifting of vC-O towards
higher frequency (~ 1330-1345 cm-1) and lowering of vC=N (~ 1590-1620 cm-1) suggested that the
co-ordination of the Schiff-bases occurred through the deprotonated oxygen of the phenolic-OH
group and nitrogen of the azomethine (HC=N) groups19-21.
Further conclusive evidence of the co-ordination of the ligand with the metal was confirmed by the
appearance of weak low frequency bands at 485-520 and 355-370 cm-1 (Table 2) due to metal-
oxygen and metal-nitrogen stretching vibrations22 in the metal complexes and not observed in the
spectra of Schiff-bases.
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Table 1.
No
10
11
12
13
14
15
17
18
19
2O
21
22
23
24
and Data of Metal
Metal che]ate/Mol. Formula
[Ni(L1)2(NO3)2]
C20H12NiN8012S2 [678.82]
[Ni(L1)2(SO4)]
C20H12NiN6010S3 [650.88]
[Ni(L1)2(C204)]
C22H12NiN6010S2 [642.82]
[Ni(L1)2(CH3CO2)2]
C24H18NiN6010S2 [672.82]
[Ni(L2)2(NO3)2]
C20H12NiCIN608S2 [622.27]
[Ni(L2)2(SO4)]
C20H12NiCIN406S3 [594.33]
[Ni(L2)2(C204)]
C22H12NiCIN406S2 [586.27]
[Ni(L2)2(CH3CO2)2]
C24H18NiCIN406S2 [616.27]
[Cu(L)2(NO3)2]
C20H12CuN8012S2 [683.66]
[Cu(L1)2(SO4)]
C20H12CuN6010S3 [655.72]
[Cu(L)a(CaO4)]
022H12CuN6010S2 [647.66]
[Cu(L )2(CH3002)2]
C24H18CuN6010S2 [677.66]
[Cu(L2)2(NO3)2]
C20H12CuCIN6OsS2 [627.11]
[Cu(La)a(SO4)]
C2oH2CuCIN406S3 [599.17]
[Cu(La)a(CaO4)]
C22H12CuCIN406S2 [591.11]
[Cu(L2)2(CH3CO2)2]
C24H18CuCIN406S2 [621.11]
[Zn(L)2(NO3)2]
C20H12ZnN8012S2 [685.5]
[Zn(L)2(SO4)]
C2oH12ZnN6OloS3 [657.56]
[Zn(L)2(C204)]
C22H12ZnN6OloS2 [649.5]
[Zn(L1)2(CH3CO2)2]
C24H18ZnN6010S2 [679.50]
[Zn(L2)2(NO3)2]
[628.95]
[Zn(L2)2(SO4)]
C20H12ZnCIN406S3 [601.01]
[Zn(L2)2(C204)]
C22H12ZnCIN406S2 [592.95]
[Zn(L2)2(CH3CO2)2]
C24H18ZnCIN4OsS2 [622.95]
Chelates
M.P(C)
(decom)
252-254
264-266
258-260
255-257
250-252
261-262
258-260
252-254
255-257
248-250
250-252
245-247
255-257
254-256
252-254
250-252
258-260
264-266
261-263
260-262
263-265
265-267
259-261
260-262
B,M.
3.10
2.91
2.96
3.20
3.10
2.90
3.10
2.98
1.92
1.87
1.91
1.90
1.88
1.89
1.91
1.90
Dia
Dia
Dia
Dia
Dia
Dia
Dia
Dia
Cal (Found)%
C H N
35.4 1.8 16.5
(35.7)(2.0)(16.2)
36.9 1.8 12.9
(37.2)(2.2)(12.5)
41.1 1.9 13.1
(41.5)(2.1)(12.8)
42.8 2.7 12.5
(42.9)(2.5)(12.3)
38.6 1.9 13.5
(38.9)(2.0)(13.1)
40.4 2.0 9.4
(40.9)(1.8)(9.9)
45.0 2.0 9.6
(45.6)(2.4)(9.2)
46.7 2.9 9.1
(46.8)(3.2)(8.8)
35.1 1.8 16.4
(35.4)(2.2)(16.1)
36.6 1.8 12.8
(36.9)(2.0)(12.5)
40.8 1.9 13.0
(41.0)(2.2)(13.5)
42.5 2.7 12.4
(42.1)(2.9)(12.0)
38.3 1.9 13.4
(38.7)(2.4)(13.3)
40.1 2.0 9.3
(40.3)(2.4)(9.1)
44.7 2.0 9.5
(44.9)(2.2)(9.7)
46.4 2.9 9.0
(46.5)(3.3)(9.1)
35.0 1.8 16.3
(35.2)(2.1)(16.5)
36.5 1.8 12.8
(36.3)(2.0)(12.6)
40.6 1.8 12.9
(40.9)(2.1)(13.3)
42.4 2.6 12.4
(42.1)(2.8)(12.3)
38.2 1.9 13.4
(38.7)(2.2)(13.7)
40.0 2.0 9.3
(40.4)(2.2)(9.1)
44.5 2.0 9.4
(44.7)(2.6)(9.5)
46.2 2.9 9.0
(46.5)(3.1)(8.8)
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UV-Visible spectra and Magnetic moments
The electronic spectra of the Ni(ll) complexes exhibited four bands at 7915-8955, 14225-14875,
24225-24760 and 29550-30125 cm-. The first three bands were assigned to the spin-allowed
transitions 3A2g(v)-->3Tg, 3Ag(v)3T9(F) and 3Ag(v3)-3Tg(P respectively. The fourth band at
29550-30125 cm-
was of high intensity band due to ligand-metal charge-transfer. The occurrence
of three spin-allowed transitions supported an octahedral geometry for the Ni(ll) complexes23. The
magnetic moments of Ni(ll) complexes also lie in the range 2.9-3.2 B.M (Table 1) and confirm the
octahedral geometry4.
Table 2. Spectral Data of Metal(ll) Chelates
No IR (cm-1) Zrnax (cm-1)
1 1330 (C-O), 1620 (HC=N), 480 (M-O), 345 (M-N) 29550, 24760, 14545, 8955
2 1345 (C-O), 1615 (HC=N), 485 (M-O), 355 (M-N) 29775, 24225, 14875, 8270
3 1135 (C-O), 1595 (HC=N), 490 (M-O), 350 (M-N) 30125, 24790, 14285, 8555
4 1345 (C-O), 1610 (HC=N), 495 (M-O), 355 (M-N) 29555, 24265, 14570, 7915
5 1330 (C-O), 1602 (HC=N), 505 (M-O), 365 (M-N) 30225, 24775, 14545, 8345
6 1335 (C-O), 1590 (HC=N), 510 (M-O), 355 (M-N) 29750, 24315, 14555, 8280
7 1335 (C-O), 1595 (HC=N), 505 (M-O), 365 (M-N) 30510, 24790, 14225, 8550
8 1340 (C-O), 1620 (HC=N), 495 (M-O), 360 (M-N) 29655, 24280, 14570, 7975
9 1340 (C-O), 1615 (HC=N), 490 (M-O), 345 (M-N) 27110, 14235
10 1338 (C-O), 1610 (HC=N), 495 (M-O), 345 (M-N) 27245, 14530
1 1 1330 (C-O), 1605 (HC=N), 485 (M-O), 355 (M-N) 28500, 15350
1 2 1345 (C-O), 1620 (HC=N), 510 (M-O), 365 (M-N) 28170, 15100
13 1330 (C-O), 1620 (HC=N), 480 (M-O), 345 (M-N) 29245, 14530
14 1345 (C-O), 1615 (HC=N), 485 (M-O), 355 (M-N) 29375, 14530
15 1135 (C-O), 1595 (HC=N), 490 (M-O), 350 (M-N) 28450, 14875
16 1345 (C-O), 1610 (HC=N), 495 (M-O), 355 (M-N) 28170, 15345
17 1330 (C-O), 1602 (HC=N), 505 (M-O), 365 (M-N) 28250
18 1335 (C-O), 1590 (HC=N), 510 (M-O), 355 (M-N) 29255
1 9 1335 (C-O), 1595 (HC=N), 505 (M-O), 365 (M-N) 29515
20 1340 (C-O), 1620 (HC=N), 495 (M-O), 360 (M-N) 28275
21 1340 (C-O), 1615 (HC=N), 490 (M-O), 345 (M-N) 29250
22 1338 (C-O), 1610 (HC=N), 495 (M-O), 345 (M-N) 28445
23 1330 (C-O), 1605 (HC=N), 485 (M-O), 355 (M-N) 28270
24 1345 (C-O), 1620 (HC=N), 510 (M-O), 365 (M-N) 29355
The electronic spectra of the Cu(ll) com)lexes exhibited 2bo bnds, a broad unsymmetrical band in
the visible region at 14235-15350 cm- may be due to Eg--) T.2g transitions for their octahedral
geometry_ and a sharp band of high intensity at 27110-29375 cm-assigned to ligand-metal charge-
transfer25. The magnetic moments of the Cu(ll) complexes lie in the range 1.87-1.92 B.M
expected26,27 for their distorted octahedral environment. The electronic spectra of the Zn(ll)
complexes exhibited only a high intensity band at 28250-29515 cm-1 assigned28 to ligand-metal
charge-transfer.
In the light of the above discussion an octahedral structure for the Ni(ll) and Zn(ll) chelates arid a
distorted octahedml structure for the Cu(ll) chelates is proposed and it is tentatively proposed that
the Schiff-bases coordinate through the nitrogen of the azomethine group, nitrogen of thiazole ring
and deprotonated oxygen of phenolic group forming a stable chelate ring (Fig 2).
Antibacterial Studies
The antibacterial activity of Schiff-bases in comparison to its metal chelates having the same metal
atom but different anions was studied against bacterial species Escherichia coli, Staphylococcus
aureus and Pseudomonas aeruginosa. Paper disc diffusion method reported29-31 earlier was
adopted for screening. The Schiffobases and their complexes individually exhibited varying degrees
of inhibitory effects on the growth of the tested bacterial species. The antibacterial results
reproduced in Table 3 evidently show that the activity of the Schiff-bases became more
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R
M=Ni(II), Cu(ll) or Zn(ll)
Proposed Structure of the Metal(ll) chelate
Table 3 Antibacterial Activity Data
Schiff-base/ M c r o
Chelate a
HL +
HL2 ++
1 +++
2 +++
3 +++
4 +++
5 ++++
6 +++
7 ++++
8 ++
9 +++
’10 +++
1 1 +++
12 ++
13 +++
14 +++
15 +++
16 +++
17 ++++
18 +++
1 9 ++++
20 ++
21 +++
22 +++
23 +++
24 ++
a= Eschedchia coil,
bial S
b
++
+
+++
+++
++++
++
+++
+++
+++
+++
+++
+++
++++
++++
+++
+++
++++
++
+++
+++
+++
+++
+++
+++
++++
pecies
C
+
/
++
/
++++
+++
++
+++
+++
+++
+++
++
+++
+++
+++
+
++++
+++
++
+++
b= Staphylococcus aureus, c= Pseudomonas aeruginosa
Inhibition zone diameter mm (% inhibition): +, 6-10 (27-45 %); ++, 10-14
(45-64 %); +++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values are
relative to inhibition zone (22 mm) of the most active compound with 100 % inhibition.
pronounced when co-ordinated to these metals. When the same metal chelate having different
anions was individually screened the degree of bactericidal activity/potency also varied. From the
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obtained data, it was generally observed that the order of potency in comparison to the metal
complexes having chloride anions evaluated and reported earlieras and to the results of the present
studies against the same tested bacterial species under the same conditions were found to follow
the order as:
NO3 > C204 > CH3002 > CI > SO4
On the basis of these results, it is strongly claimed that different anions dominantly effect the
biological behavior of the metal chelates. It is however suspected that factors such as solubility,
conductivity, dipole moment and cell permeability mechanisms are certainly influenced by the
presence of these anions in the chelate and may cause in increasing this activity/potency. Further in
vivo studies are in progress, which would help the authors to establish the real mechanism and role
of anions in increasing this biological activity.
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